维京治疗 VKTX
$26.84 +$1.05 (+4.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $26.80 -0.15%
开盘$25.81
昨收$25.79
当日区间$25.55 – $27.03
成交量2.67M
市值$3.42B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$0.00
营业利润-$187.11M-89.8% YoY
净利润-$183.19M-101.8% YoY
摊薄每股收益-$1.55-91.4% YoY
自由现金流-$138.19M-47.0% YoY
经营现金流-$138.19M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-96.4%
资产收益率-73.1%
投入资本回报率-83.3%
流动比率7.27
负债/资产比率39.8%
现金及投资$959.81M
总负债$254.67M
净现金（净负债）$705.14M
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $187.11M | $132.60M | $164.13M | $393.34M | $164.74M |
| 销售及管理费用 | $20.31M | $16.84M | $13.98M | $48.39M | $11.28M |
| -管理费用 | $20.31M | $16.84M | $13.98M | $48.39M | $11.28M |
| 研发费用 | $166.80M | $115.75M | $150.15M | $344.96M | $153.46M |
| 营业利润 | -$187.11M | -$132.60M | -$164.13M | -$393.34M | -$164.74M |
| 非经营性利息净收入（支出） | $3.93M | $4.55M | $5.80M | $33.65M | $7.04M |
| 非经营性利息收入 | $4.01M | $4.55M | $5.80M | $33.70M | $7.04M |
| 非经营性利息支出 | $88,000.00 | – | – | – | – |
| 税前利润 | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| 净利润 | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| 持续经营利润 | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| 归属母公司净利润 | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| 归属普通股股东净利润 | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| 基本每股收益 | -$1.55 | -$1.10 | -$1.37 | -$3.19 | -$1.38 |
| 摊薄每股收益 | -$1.55 | -$1.10 | -$1.37 | -$3.19 | -$1.38 |
| 其他收入（支出） | – | $30,000.00 | – | $55,000.00 | $41,000.00 |
| 证券出售收益 | – | $30,000.00 | – | $55,000.00 | $41,000.00 |
| 其他财务成本合计 | – | – | – | $56,000.00 | $0.00 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $977.17M | $521.90M | $608.24M | $715.73M | $715.73M |
| 流动资产合计 | $973.00M | $517.56M | $608.21M | $715.60M | $715.60M |
| 现金及现金等价物与短期投资 | $959.81M | $501.66M | $602.96M | $705.74M | $705.74M |
| -现金及现金等价物 | $677.61M | $125.75M | $118.12M | $165.81M | $165.81M |
| -短期投资 | $282.20M | $375.91M | $484.85M | $539.93M | $539.93M |
| 预付资产 | $10.01M | $14.96M | $4.02M | $8.05M | $8.05M |
| 其他流动资产 | $3.18M | $941,000.00 | $1.22M | $1.81M | $1.81M |
| 非流动资产合计 | $4.17M | $4.33M | $33,000.00 | $131,000.00 | $131,000.00 |
| 固定资产净值 | $3.85M | $4.01M | $0.00 | $85,000.00 | $85,000.00 |
| -固定资产原值 | $3.85M | $4.01M | $0.00 | $85,000.00 | $85,000.00 |
| 一年以上预付资产 | $113,000.00 | $113,000.00 | $33,000.00 | $46,000.00 | $46,000.00 |
| 其他非流动资产 | $202,000.00 | $211,000.00 | – | – | – |
| 负债合计 | $388.57M | $113.58M | $106.33M | $76.67M | $76.67M |
| 流动负债合计 | $133.90M | $109.66M | $106.33M | $76.67M | $76.67M |
| 应付款 | $82.13M | $69.01M | $67.18M | $53.25M | $53.25M |
| -应付账款 | $82.13M | $69.01M | $67.18M | $53.25M | $53.25M |
| 一年内应计费用 | $51.74M | $40.48M | $39.14M | $23.28M | $23.28M |
| 短期债务及融资租赁负债 | $24,000.00 | $161,000.00 | – | $137,000.00 | $137,000.00 |
| -一年内到期融资租赁负债 | $24,000.00 | $161,000.00 | $0.00 | $137,000.00 | $137,000.00 |
| 非流动负债合计 | $254.67M | $3.93M | $0.00 | $0.00 | $0.00 |
| 长期债务及融资租赁负债 | $254.67M | $3.93M | – | $0.00 | $0.00 |
| -长期债务 | $250.66M | – | – | – | – |
| -长期融资租赁负债 | $4.01M | $3.93M | – | $0.00 | $0.00 |
| 股东权益合计 | $588.60M | $408.32M | $501.92M | $639.06M | $639.06M |
| 股东权益 | $588.60M | $408.32M | $501.92M | $639.06M | $639.06M |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.91B | $1.54B | $1.51B | $1.49B | $1.49B |
| 留存收益 | -$1.32B | -$1.13B | -$1.01B | -$847.55M | -$847.55M |
| 不影响留存收益的损益 | -$1.70M | -$1.15M | -$856,000.00 | $378,000.00 | $378,000.00 |
| 减：库存股 | – | – | $0.00 | $0.00 | $0.00 |
| 一年以上递延资产 | – | – | – | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$138.19M | -$125.17M | -$113.98M | -$278.69M | -$85.29M |
| 持续经营经营活动现金流净额 | -$138.19M | -$125.17M | -$113.98M | -$278.69M | -$85.29M |
| 持续经营净利润 | -$183.19M | -$128.02M | -$158.33M | -$359.64M | -$157.66M |
| 持续经营损益 | $0.00 | – | – | -$55,000.00 | -$41,000.00 |
| 折旧、折耗与摊销 | $158,000.00 | $157,000.00 | $85,000.00 | $431,000.00 | $94,000.00 |
| 其他非现金项目 | $91,000.00 | $111,000.00 | $1,000.00 | $66,000.00 | -$16,000.00 |
| 营运资金变动 | $27.65M | -$7.64M | $35.22M | $48.98M | $65.48M |
| -应收款变动 | $1.47M | $120,000.00 | $936,000.00 | $5.08M | $413,000.00 |
| -预付资产变动 | $2.71M | -$10.74M | $4.63M | -$5.20M | $14.28M |
| -应付账款及应计费用变动 | $23.61M | $3.17M | $29.79M | $49.61M | $50.90M |
| -其他流动负债变动 | -$139,000.00 | -$191,000.00 | -$139,000.00 | -$505,000.00 | -$116,000.00 |
| 投资活动现金流净额 | $92.52M | $109.43M | $54.19M | $341.39M | $75.61M |
| 持续经营投资活动现金流净额 | $92.52M | $109.43M | $54.19M | $341.39M | $75.61M |
| 投资购置及出售净额 | $92.52M | $109.43M | $54.19M | $341.39M | $75.61M |
| 筹资活动现金流 | $597.55M | $23.59M | $12.08M | $76.44M | $75.10M |
| 持续经营筹资活动现金流净额 | $597.55M | $23.59M | $12.08M | $76.44M | $75.10M |
| 股票期权行使所得 | $753,000.00 | $1.01M | $450,000.00 | $2.49M | $1.16M |
| 其他筹资费用净额 | $48.52M | – | – | $73.95M | – |
| 期末现金余额 | $677.81M | $125.96M | $118.12M | $165.81M | $165.81M |
| 现金净变动 | $551.88M | $7.85M | -$47.71M | $139.14M | $65.43M |
| 期初现金余额 | $125.96M | $118.12M | $165.81M | $26.68M | $100.38M |
| 汇率变动影响 | -$26,000.00 | $0.00 | $16,000.00 | -$8,000.00 | $9,000.00 |
| 自由现金流 | -$138.19M | -$125.17M | -$113.98M | -$278.69M | -$85.29M |
| 普通股发行净额 | – | – | $11.63M | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 VKTX。
登录后参与讨论。